Clinical Trial: Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb): a Prospective Cohort Study
Brief Summary: Study of seroprevalence of hepatitis E among HIV positive patient in Basque country, France in 2016.
Detailed Summary: Study of seroprevalence of hepatitis E among patient followed and treated in "centre Hospitalier de la Côte Basque" for HIV infections. Study of acquisition of hepatitis E , and determination of liver status using fibrotest in co-infected patients with hepatis C and / or B.
Sponsor: Centre Hospitalier de la côte Basque
Current Primary Outcome: Prevalence of immunoglobulin M (IgM) and Immunoglobulin G (IgG) for hepatitis E in blood sample of each patients. Positive sample for both IgM and IgG will be confirmed using polymerase chain reaction (PCR) techniques [ Time Frame: 6 months time period ]
Original Primary Outcome: Same as current
Current Secondary Outcome: fibrotest score [ Time Frame: 6 months time period ]
Original Secondary Outcome: Same as current
Information By: Centre Hospitalier de la côte Basque
Dates:
Date Received: July 20, 2016
Date Started: July 2016
Date Completion: January 2017
Last Updated: July 27, 2016
Last Verified: July 2016